Gut radiation + immunotherapy: a new hope for tough esophageal cancers?
NCT ID NCT07339488
Summary
This study is testing a new combination treatment for people with esophageal cancer that is difficult or impossible to remove with surgery right away. The goal is to see if adding a very low dose of radiation to the intestines to an immunotherapy and chemotherapy regimen can shrink tumors enough to make surgery possible. The study will enroll about 43 adults with this specific type of cancer to see how well the treatment works and how safe it is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital, Shantou University Medical College
Shantou, Guangdong, 515031, China
Conditions
Explore the condition pages connected to this study.